Zobrazeno 1 - 10
of 36
pro vyhledávání: '"C. P. Belani"'
Autor:
C P, Belani
Publikováno v:
Clinical lung cancer. 1(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09c872040d96f4f8fe61ba2ab798d4d9
https://pubmed.ncbi.nlm.nih.gov/14733638
https://pubmed.ncbi.nlm.nih.gov/14733638
Autor:
C P, Belani
Publikováno v:
Clinical lung cancer. 2(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2105d736e7a23d66330bd85c5b900f45
https://pubmed.ncbi.nlm.nih.gov/14731317
https://pubmed.ncbi.nlm.nih.gov/14731317
Autor:
C P, Belani
Publikováno v:
Clinical lung cancer. 2(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a83b8b6319afdfbd468c7382345cd8a
https://pubmed.ncbi.nlm.nih.gov/14731330
https://pubmed.ncbi.nlm.nih.gov/14731330
Autor:
C P, Belani
Publikováno v:
Clinical lung cancer. 2
The four chemotherapy regimens evaluated in Eastern Cooperative Oncology Group study 1594 (paclitaxel/ cisplatin, gemcitabine/cisplatin, docetaxel/cisplatin, and paclitaxel/carboplatin) are effective treatment options for the therapy of advanced non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8b05e65f1fce7571965ddafd5b1ed95
https://pubmed.ncbi.nlm.nih.gov/14725729
https://pubmed.ncbi.nlm.nih.gov/14725729
Autor:
C P, Belani
Publikováno v:
Clinical lung cancer. 3(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::212bda075f9529464582efe3dddb7711
https://pubmed.ncbi.nlm.nih.gov/14659021
https://pubmed.ncbi.nlm.nih.gov/14659021
Autor:
C P, Belani
Publikováno v:
Clinical lung cancer. 3(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::098273a707ded6a9b043d79fd7f0385f
https://pubmed.ncbi.nlm.nih.gov/14656382
https://pubmed.ncbi.nlm.nih.gov/14656382
Autor:
C J, Sweeney, J, Zhu, A B, Sandler, J, Schiller, C P, Belani, C, Langer, J, Krook, D, Harrington, D H, Johnson
Publikováno v:
Cancer. 92(10)
Eastern Cooperative Oncology Group (ECOG) Study E1594 compared paclitaxel and cisplatin with three newer chemotherapy doublets in the treatment of patients with advanced nonsmall cell lung carcinoma (NSCLC). The accrual of patients with an ECOG perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::519e661e59c94a34d949a673bada5c8f
https://pubmed.ncbi.nlm.nih.gov/11745199
https://pubmed.ncbi.nlm.nih.gov/11745199
Autor:
A R, Calvo, C P, Belani
Publikováno v:
Cancer treatment and research. 105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0809a56825a9c57a5ab8a3f870369e46
https://pubmed.ncbi.nlm.nih.gov/11224988
https://pubmed.ncbi.nlm.nih.gov/11224988
Publikováno v:
Surgical laparoscopy, endoscopypercutaneous techniques. 9(3)
Photodynamic therapy (PDT) was recently approved by the Food and Drug Administration for palliating obstructing esophageal cancer. This report reviews our initial experience using PDT to treat malignant dysphagia. Patients with inoperable, obstructin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::908115dc6f3c9cfe937ee218e305676c
https://pubmed.ncbi.nlm.nih.gov/10803993
https://pubmed.ncbi.nlm.nih.gov/10803993
Autor:
C P, Belani
Publikováno v:
Chest. 117(4 Suppl 1)
Over the last decade, we have witnessed improved outcome among patients with non-small cell lung cancer (NSCLC), principally through the use of new and novel treatment programs. A meta-analysis of randomized clinical trials comparing combined chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18f320b7e30f7ad9bc9c5a3247540911
https://pubmed.ncbi.nlm.nih.gov/10777467
https://pubmed.ncbi.nlm.nih.gov/10777467